newsfilter
← Latest News
GlobeNewswire·

Cassava Sciences Licenses Simufilam Method of Treatment Patent

Cassava enters into a license agreement with Yale University granting intellectual property rights, including rights to an issued US method of treatment patent for potential treatment with simufilam of seizures related